Improving quality of life for stroke patients using the Armeo Spring device
Evaluation of the Effect of Rehabilitation Using the Armeo Spring Device on Improving the Quality of Motion of Upper Extremity in Patients in the Sub-acute Stage After Stroke and Its Correlation With the Rate of Improvement in the Quality of Life After Completing Rehabilitation
This study tests if using the Armeo Spring device can help stroke patients move better and improve their quality of life compared to regular therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | University Hospital Ostrava Academic / other |
| Locations | 1 site (Ostrava, Moravian-Silesian Region) |
| Trial ID | NCT05743413 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of the Armeo Spring device on the quality of movement in stroke patients and its subsequent effect on their quality of life. It involves a prospective monocentric randomized design where participants are divided into two groups: one receiving therapy with the Armeo Spring and the other receiving standard physiotherapy. The study will last for 8 months and will assess changes in self-sufficiency through standardized questionnaires and daily activity tests. The aim is to determine if the innovative device can enhance rehabilitation outcomes compared to conventional methods.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years with a history of ischemic stroke and moderate upper extremity paresis.
Not a fit: Patients with severe cognitive deficits, instability, or other significant health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the rehabilitation outcomes and quality of life for stroke patients.
How similar studies have performed: Previous studies have shown promise in using innovative rehabilitation devices for stroke recovery, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * history of stroke * age over 18 years * Modified Rankin Scale (mRS) of 2-3 * moderate paresis of the upper extremity (individuals with shoulder/elbow muscle test values in the range of 3-1) * cardiovascular stability Exclusion Criteria: * age under 18 years * severe cognitive or sensory deficit and non-cooperation * severe osteoporosis * impaired skin integrity in the trunk and upper limbs * cardiovascular instability * unstable fractures * acute inflammatory diseases
Where this trial is running
Ostrava, Moravian-Silesian Region
- University Hospital Ostrava — Ostrava, Moravian-Silesian Region, Czechia (Recruiting)
Study contacts
- Principal investigator: Šárka Anežka Čechová, MD — University Hospital Ostrava
- Study coordinator: Jiří Hynčica
- Email: jiri.hyncica@fno.cz
- Phone: 0042059737
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.